// COMPANY
Kailera Therapeutics
SECTOR BIOTECHMENTIONS 3LAST SEEN JULY 27, 2026
// OVERVIEW
Bain Capital-backed biopharma company focused on obesity drugs that raised a $625M IPO.
Discussed in
// RECENT MENTIONS
// SIGNALS
3 SIGNALS
01
product·PitchBook News·JULY 27, 2026
“IPO activity also had a strong quarter, with back-to-back record-setting debuts from Kailera Therapeutics and Parabilis Medicines.”
Source→02
mention·PitchBook News·JUNE 11, 2026
“Parabilis Medicines has broken the record for the largest VC-backed biotech IPO, just weeks after Kailera Therapeutics took the crown.”
Source→03
funding·PitchBook News·APRIL 20, 2026
“Kailera Therapeutics | Biopharma; obesity drug focus | Bain Capital-backed; raised $625M IPO”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.